Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion type Assertion NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_head.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion description "[Clinical investigations have suggested that repression of the TGF-? type II receptor (T?RII) may be an important step in progression of lung adenocarcinoma from an indolent in situ state to a frank invasive carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_provenance.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion evidence source_evidence_literature NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_provenance.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion SIO_000772 21911454 NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_provenance.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion wasDerivedFrom befree-20140225 NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_provenance.
- NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_assertion wasGeneratedBy ECO_0000203 NP870079.RA2ey6AXwF0UTnL0nMBEA08TSaTSDGXFHlVnZaMiVMtrw130_provenance.